📰 Keyes Plant News
Page 2 - Keyes Plant News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Keyes Plant. Real-time updates on events, politics, business and more.
April 25, 2023
Aemetis, Inc. (NASDAQ:AMTX – Get Rating) has earned a consensus recommendation of “Hold” from the seven ratings firms that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have issued a buy recommendation on the company. The average […]
April 19, 2023
Aemetis, Inc. (NASDAQ:AMTX – Get Rating) was the target of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 6,840,000 shares, a decline of 9.9% from the March 15th total of 7,590,000 shares. Based on an average daily trading volume, of 582,300 shares, the […]
April 18, 2023
Aemetis (NASDAQ:AMTX – Get Rating) had its target price lowered by Stifel Nicolaus from $18.00 to $10.00 in a research note published on Friday morning, The Fly reports. The brokerage currently has a buy rating on the specialty chemicals company’s stock. Several other brokerages also recently commented on AMTX. Truist Financial lowered their price objective […]
April 17, 2023
Aemetis (NASDAQ:AMTX – Get Rating) had its target price trimmed by Truist Financial from $5.00 to $2.50 in a research report sent to investors on Thursday, The Fly reports. Separately, Piper Sandler initiated coverage on Aemetis in a research report on Monday, February 27th. They issued an underweight rating and a $3.00 target price on […]
April 17, 2023
Aemetis (NASDAQ:AMTX – Get Rating) had its price target decreased by Stifel Nicolaus from $18.00 to $10.00 in a research note released on Friday morning, The Fly reports. Other research analysts also recently issued reports about the stock. Piper Sandler started coverage on shares of Aemetis in a research report on Monday, February 27th. They […]
March 29, 2023
Shares of Aemetis, Inc. (NASDAQ:AMTX – Get Rating) have been given an average rating of “Hold” by the six research firms that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation and one has issued a buy recommendation on […]
August 8, 2022
Our Managements Discussion and Analysis of Financial Condition and Results of Operations is provided in addition to the accompanying consolidated condensed financial statements and notes to assist... | August 8, 2022
March 21, 2022
Equities analysts predict that Aemetis, Inc. (NASDAQ:AMTX – Get Rating) will post earnings of ($0.35) per share for the current quarter, Zacks reports. Three analysts have issued estimates for Aemetis’ earnings, with the lowest EPS estimate coming in at ($0.38) and the highest estimate coming in at ($0.32). Aemetis reported earnings of ($0.69) per share […]
March 12, 2022
Aemetis (NASDAQ:AMTX – Get Rating) posted its earnings results on Thursday. The specialty chemicals company reported ($0.03) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.26) by $0.23, Fidelity Earnings reports. During the same period last year, the business posted ($0.68) EPS. Shares of AMTX traded down $0.80 during […]
February 28, 2022
Wall Street analysts expect that Aemetis, Inc. (NASDAQ:AMTX – Get Rating) will post $55.87 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Aemetis’ earnings. The highest sales estimate is $61.00 million and the lowest is $49.00 million. Aemetis posted sales of $37.33 million during the same quarter […]